Tevogen (TVGN) Cash from Financing Activities (2023 - 2026)
Tevogen's Cash from Financing Activities was $2.87 million in Q1 2026, down 28.2% from $4 million a year earlier but up 63.2% from the prior quarter.
Powered by 
Analysis
Tevogen (TVGN) Cash from Financing Activities (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Tevogen's Cash from Financing Activities was $10.54 million through Mar 31, 2026, down 23.7% year-over-year; for FY2025, it came in at $11.66 million, down 4.6% from FY2024.
- Cash from Financing Activities shows a four-year compound annual growth rate of -57.4% (FY2021 to FY2025).
- In earlier years, Cash from Financing Activities was $12.23 million in FY2024 (+215.8%), $3.87 million in FY2023 and $352.96 million in FY2021.
- Quarterly Cash from Financing Activities has moved between $422,250 (Q4 2023) and $5 million (Q3 2024) over five years.
- Compared with a year earlier, Cash from Financing Activities has declined for four straight quarters, with growth averaging 110.3% over the last seven quarters.
- The best year-over-year quarter for Cash from Financing Activities over five years was Q3 2024 (growth of 426.3%); the worst was Q2 2025 (a decline of 32.1%).
- Per Business Quant data, TVGN's Cash from Financing Activities in the three quarters before Q1 2026 was $1.76 million (Q4 2025), $4 million (Q3 2025) and $1.9 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 8.43 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | -8.53 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | -5.05 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 1.76 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | -2.02 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | -3.89 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | -1.48 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 2.34 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | -3.66 Bn |
| 10 | Tevogen | 24.97 Mn | 24.97 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.87 Mn |
| Dec 31, 2025 | 1.76 Mn |
| Sep 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 1.90 Mn |
| Mar 31, 2025 | 4.00 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | 2.80 Mn |
| Mar 31, 2024 | 2.43 Mn |
| Dec 31, 2023 | 422,250.00 |
| Sep 30, 2023 | 950,000.00 |
| Mar 31, 2023 | 2.50 Mn |
API Access
Tevogen Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TVGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "TVGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=TVGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();